2024 Q4 Form 10-Q Financial Statement
#000149315224052355 Filed on December 30, 2024
Income Statement
Concept | 2024 Q4 | 2024 Q3 | 2024 Q2 |
---|---|---|---|
Revenue | |||
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | |||
YoY Change | |||
Operating Profit | -$20.47K | ||
YoY Change | 203.45% | ||
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | -$6.00 | ||
YoY Change | |||
Pretax Income | -$20.47K | ||
YoY Change | 203.54% | ||
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$20.47K | ||
YoY Change | 203.54% | ||
Net Earnings / Revenue | |||
Basic Earnings Per Share | $0.00 | ||
Diluted Earnings Per Share | $0.00 | ||
COMMON SHARES | |||
Basic Shares Outstanding | 50.32M shares | 50.32M shares | 50.32M shares |
Diluted Shares Outstanding | 50.32M shares |
Balance Sheet
Concept | 2024 Q4 | 2024 Q3 | 2024 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $1.092K | $842.00 | |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | |||
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | |||
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | |||
Total Long-Term Assets | |||
Total Assets | $1.092K | $842.00 | |
YoY Change | -19.17% | -61.5% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | |||
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | |||
YoY Change | |||
LONG-TERM LIABILITIES | |||
Long-Term Debt | |||
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | |||
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | |||
Total Long-Term Liabilities | |||
Total Liabilities | $158.4K | $137.7K | |
YoY Change | 96.38% | 84.18% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$6.592M | -$6.572M | |
YoY Change | 1.2% | 0.99% | |
Common Stock | $5.032K | $5.032K | |
YoY Change | 0.0% | 0.0% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$157.3K | -$136.9K | |
YoY Change | |||
Total Liabilities & Shareholders Equity | $1.092K | $842.00 | |
YoY Change | -19.17% | -61.5% |
Cashflow Statement
Concept | 2024 Q4 | 2024 Q3 | 2024 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$20.47K | ||
YoY Change | 203.54% | ||
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$13.29K | ||
YoY Change | 35.15% | ||
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | |||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $13.54K | ||
YoY Change | 50.48% | ||
NET CHANGE | |||
Cash From Operating Activities | -$13.29K | ||
Cash From Investing Activities | |||
Cash From Financing Activities | $13.54K | ||
Net Change In Cash | $250.00 | ||
YoY Change | -129.9% | ||
FREE CASH FLOW | |||
Cash From Operating Activities | -$13.29K | ||
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q3 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2025 | |
CY2024Q3 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--06-30 | |
CY2023Q3 | LGYV |
Bank Charges And Other
BankChargesAndOther
|
usd | |
CY2024Q3 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2023Q3 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2024Q3 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
CY2023Q3 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
CY2024Q3 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
30-0826318 | |
CY2024Q3 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
Unit 01, 82/F. International Commerce Centre | |
CY2024Q3 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
1 Austin Road West | |
CY2024Q3 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Kowloon | |
CY2024Q3 | dei |
Entity Address Country
EntityAddressCountry
|
HK | |
CY2023Q4 | us-gaap |
Payments For Fees
PaymentsForFees
|
1410 | usd |
CY2024Q3 | dei |
City Area Code
CityAreaCode
|
+852 | |
CY2024Q3 | dei |
Local Phone Number
LocalPhoneNumber
|
3960 6394 | |
CY2024Q3 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2024Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
50315064 | shares |
CY2024Q3 | dei |
Entity Listing Par Value Per Share
EntityListingParValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Cash
Cash
|
1092 | usd |
CY2024Q2 | us-gaap |
Cash
Cash
|
842 | usd |
CY2024Q3 | us-gaap |
Assets
Assets
|
1092 | usd |
CY2024Q2 | us-gaap |
Assets
Assets
|
842 | usd |
CY2024Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
39082 | usd |
CY2024Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
31904 | usd |
CY2024Q2 | us-gaap |
Liabilities
Liabilities
|
137711 | usd |
CY2024Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2024Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2024Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2024Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
50315064 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
50315064 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
50315064 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
50315064 | shares |
CY2024Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
5032 | usd |
CY2024Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
6429771 | usd |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-6571672 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-136869 | usd |
CY2024Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
842 | usd |
CY2024Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
19742 | usd |
CY2024Q3 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
723 | usd |
CY2023Q3 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
1244 | usd |
CY2024Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-20465 | usd |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6744 | usd |
CY2024Q3 | LGYV |
Bank Charges And Other
BankChargesAndOther
|
-6 | usd |
CY2024Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-6 | usd |
CY2024Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-20471 | usd |
CY2023Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-6744 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-20471 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6744 | usd |
CY2024Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2024Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.00 | |
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.00 | |
CY2024Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
50315064 | shares |
CY2024Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
50315064 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
50315064 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
50315064 | shares |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-72583 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6744 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-79327 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-136869 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-136869 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-20471 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-157340 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6744 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
7178 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-3092 | usd |
CY2024Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-13293 | usd |
CY2023Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-9836 | usd |
CY2024Q3 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
13543 | usd |
CY2023Q3 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
9000 | usd |
CY2024Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
13543 | usd |
CY2023Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
9000 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
250 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-836 | usd |
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
842 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1678 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1092 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
842 | usd |
CY2024Q3 | LGYV |
Working Capital Deficit
WorkingCapitalDeficit
|
157340 | usd |
CY2024Q2 | LGYV |
Working Capital Deficit
WorkingCapitalDeficit
|
136869 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-6592143 | usd |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-6571672 | usd |
CY2024Q3 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
13543 | usd |
CY2024Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
50315064 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
50315064 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
50315064 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
50315064 | shares |
CY2024Q3 | LGYV |
No Insider Trading Flag
NoInsiderTradingFlag
|
true | |
CY2024Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2023Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
usd | |
CY2024Q3 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2024Q3 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001616788 | |
CY2024Q3 | dei |
Document Type
DocumentType
|
10-Q | |
CY2024Q3 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2024Q3 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-09-30 | |
CY2024Q3 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2024Q3 | dei |
Entity File Number
EntityFileNumber
|
000-55849 | |
CY2024Q3 | dei |
Entity Registrant Name
EntityRegistrantName
|
LEGACY VENTURES INTERNATIONAL, INC | |
CY2024Q3 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2024Q3 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2024Q3 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2024Q3 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2024Q3 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2024Q3 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2024Q3 | us-gaap |
Liabilities
Liabilities
|
158432 | usd |
CY2024Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2024Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
5032 | usd |
CY2024Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
6429771 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-6592143 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-157340 | usd |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1092 | usd |
CY2023Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
5500 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-157340 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-20471 | usd |